Sierra Oncology
Targeted Cancer Therapies using DNAi.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD368—552m (Dealroom.co estimates Apr 2014.)
Kalamazoo Michigan (HQ)
Financials
Estimates*
EUR | 2015 |
---|---|
R&D budget | 24.0m |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.5m | Early VC | ||
$12.5m | Late VC | ||
N/A | $1.7m | Early VC | |
N/A | $4.3m | Debt | |
* | $59.5m | Series D | |
N/A | $2.7m | Debt | |
N/A | N/A | IPO | |
N/A | $103m | Post IPO Equity | |
N/A | $34.0m | Post IPO Equity | |
N/A | $135m | Secondary | |
Total Funding | AUD121m |
Related Content
Recent News about Sierra Oncology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.